Reply to “Early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi Harada disease” by Sugita et al.

Abstract

We read with great interest the article by Sugita et al. on early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi-Harada disease. We would like to share a similar experience where the subretinal fluid resolved within 2 weeks without treatment in a pregnant woman who was in her second trimester.

Vogt‐Koyanagi‐Harada disease in pregnancy: Case report and review of 32 patients in the literature

“…A sufficient description was found in 32 patients with Vogt‐Koyanagi‐Harada disease in pregnancy (Table 1). 15–44 …”

“…A sufficient description was found in 32 patients with Vogt‐Koyanagi‐Harada disease in pregnancy (Table 1 ). 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 …”

“…Vogt‐Koyanagi‐Harada disease may occur in pregnancy and pose a problem how to apply the standard of care in a pregnant woman 12–14 . In this report, we described a patient who developed Vogt‐Koyanagi‐Harada disease in pregnancy and also summarized 32 patients with the disease in pregnancy in the literature to elucidate the outcome of treatment 15–44 …”

“… 12 , 13 , 14 In this report, we described a patient who developed Vogt‐Koyanagi‐Harada disease in pregnancy and also summarized 32 patients with the disease in pregnancy in the literature to elucidate the outcome of treatment. 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 …”